Replies to post #423329 on Anavex Life Sciences Corp (AVXL)

[WilliamMunny]

Indeed, Hoskuld, the efficacy of the placebo is remarkable - so much so that one wonders if the FDA will approve it as well as donanemab - slightly less efficacious, but far lesser concern over side effects. Surely cheaper to produce. If the manufacturer is a publicly traded company perhaps we should go long...